Roy Robertson, MD
Interventional Cardiology · Fort Wayne, INNPI 1366434342
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,606 of the $2,085 with a category attached, or 77.0%. 6 manufacturers reported payments, led by Abbott at 55.2% of the total. Reporting peaked in 2019 at $1,164 and has fallen 85.5% since, to $169 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IN, where the typical reported total is $6,172.
Across 32 payments — averaging $65.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Edwards Lifesciences$525
- Medtronic$240
- Heartflow, Inc.$86
- Boston Scientific$66
- Shockwave Medical, Inc$18
Across 33 payments — averaging $4431.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$68K
- American Regent$61K
- Medtronic$15K
- Biotronik Inc.$2K
- Amgen$5
What the payments were for
- Travel & lodging$47923%
- Food & beverage$1,60677%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $1,150 |
| Edwards Lifesciences | 7 | $525 |
| Medtronic(2 entities) | 5 | $240 |
| Heartflow, Inc. | 1 | $86 |
| Boston Scientific | 1 | $66 |
| Shockwave Medical, Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,085 in reported general payments places this provider in the 15th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 400 | $508,410 |
| XareltoRivaroxaban | 64 | $94,798 |
| EntrestoSacubitril/Valsartan | 38 | $55,434 |
| Repatha SureclickEvolocumab | 53 | $49,316 |
| JardianceEmpagliflozin | 25 | $36,694 |
| Praluent PenAlirocumab | 15 | $17,006 |
| Metoprolol Succinate | 561 | $6,720 |
| Carvedilol | 501 | $3,793 |
| Atorvastatin Calcium | 471 | $3,264 |
| Potassium Chloride | 132 | $3,077 |
| Ranolazine ErRanolazine | 24 | $3,045 |
| Torsemide | 99 | $2,917 |
| Amiodarone Hcl | 121 | $2,884 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 107 | $2,764 |
| Rosuvastatin Calcium | 305 | $2,482 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Fort Wayne
- Muzammil MusaniFort Wayne$184K
- Christopher SmitsonFort Wayne$24K
- Vijay ChilakamarriFort Wayne$21K
- Samer AbbasEast Chicago$395K
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Dean FerreraEast Chicago$180K
- Shashidhar DivakaruniMunster$97K
- Jarrod FrizzellEvansville$86K
- Navneet LatherNoblesville$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.